Analyst Downgrade Signal: ALXO from Buy to Hold by Stifel
Price Target: $10>>14
Report Date: 03-08-2024
Symbol: ALXO - ALX Oncology Holdings Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Downgrade Signal: ALXO from Buy to Hold by Stifel
Price Target: $10>>14
ALX Oncology Holdings Inc. (ALXO)
866 Malcolm Road
Burlingame, CA
Phone: 650 466 7125
Website: http://www.alxoncology.com
CEO: Dr. Jaume Pons Ph.D.
NASDAQ, Nasdaq Global Select
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic used for the treatment of myelodysplastic syndromes and acute myeloid leukemia, as well as a range of solid tumor indications, including head and neck squamous cell and human epidermal growth factor receptor 2 positive gastric/gastroesophageal junction carcinoma. The company was founded in 2015 and is based in Burlingame, California.
free stock market signals, options trade signals, stock trading signals, weekly options trading signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228